New Delhi (TIP): Mucormycosis, a fungal infection, is being found in COVID-19 patients and largely in cases of those who are diabetic but there is “no big outbreak”, Niti Aayog Member (Health) V K Paul said on Frida, May 7. The situation is being monitored and the treatment for mucormycosis is available, he said. This comes a day after a leading private hospital in Delhi flagged the rising number of COVID-triggered mucormycosis or black fungus cases. Addressing a press conference here, Paul said, “The fungal infection called mucormycosis is being found in patients of COVID-19 disease. It is caused by a fungus named mucor, which is found on wet surfaces. It, to a large extent, is happening to people who have diabetes. It is very uncommon in those who are not diabetic. There is no big outbreak and we are monitoring it.” “Mucor attacks people with uncontrolled sugar. Other than that, if the diabetes patient is taking immune suppressive medicines, steroids, or has cancer, then the impact of mucormycosis is more on that person. If these patients are exposed to wet surfaces, then the chances of getting this disease increases,” he said. Paul said drugs that suppress the immune system but are life-saving like dexamethasone, prednisolone, methylprednisolone, dexona etc., are already being used to treat COVID-19 patients. “All these are related compounds. When these are used, the immune system gets suppressed, even in persons who are diabetic, and this fungus attacks,” he said.
Black fungus found in Covid-19 patients but ‘no big outbreak’: NITI Aayog member
